| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Bridge To CAR
|
Frey, Noelle V.
|
|
|
|
6 |
p. 282-283
|
artikel
|
| 2 |
Access to Chimeric Antigen Receptor T Cell Clinical Trials in Underrepresented Populations: A Multicenter Cohort Study of Pediatric and Young Adult Acute Lymphobastic Leukemia Patients
|
Hall, Anurekha G.
|
|
|
|
6 |
p. 356.e1-356.e7
|
artikel
|
| 3 |
Addition of Astatine-211-Labeled Anti-CD45 Antibody to TBI as Conditioning for DLA-Identical Marrow Transplantation: A Novel Strategy to Overcome Graft Rejection in a Canine Presensitization Model: “Radioimmunotherapy to Overcome Transfusion-Induced Sensitization”
|
Nakaya, Aya
|
|
|
|
6 |
p. 476.e1-476.e7
|
artikel
|
| 4 |
Adenoviral Penton and Hexon Proteins Are Equivalent Immunogenic Targets of Virus-Specific T Cells after Hematopoietic Stem Cell Transplantation in Children
|
Wintering, Astrid
|
|
|
|
6 |
p. 391.e1-391.e7
|
artikel
|
| 5 |
Allogeneic Hematopoietic Stem Cell Transplantation for Adult Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia in Second Complete Remission
|
Kaito, Satoshi
|
|
|
|
6 |
p. 326.e1-326.e10
|
artikel
|
| 6 |
Allogeneic Stem Cell Transplantation in Mature T Cell and Natural Killer/T Neoplasias: A Registry Study from Spanish GETH/GELTAMO Centers
|
Novelli, Silvana
|
|
|
|
6 |
p. 493.e1-493.e8
|
artikel
|
| 7 |
A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma: Results of the Blood and Marrow Transplant Clinical Trials Network 1302 Trial
|
Bashir, Qaiser
|
|
|
|
6 |
p. 358.e1-358.e7
|
artikel
|
| 8 |
Anxiety and Depression Symptoms in Caregivers Prior to Hematopoietic Stem Cell Transplantation (HCT)
|
Waldman, Lauren P.
|
|
|
|
6 |
p. 517.e1-517.e5
|
artikel
|
| 9 |
Assessment of Salvage Regimens Post-Chimeric Antigen Receptor T Cell Therapy for Patients with Diffuse Large B Cell Lymphoma
|
Sigmund, Audrey M.
|
|
|
|
6 |
p. 342.e1-342.e5
|
artikel
|
| 10 |
Association Between Baseline Patient-Reported Outcomes and Complications of Hematopoietic Stem Cell Transplantation
|
Johnson, P. Connor
|
|
|
|
6 |
p. 496.e1-496.e5
|
artikel
|
| 11 |
ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Multiple Myeloma
|
Dhakal, Binod
|
|
|
|
6 |
p. 284-293
|
artikel
|
| 12 |
ASTCT Notes
|
|
|
|
|
6 |
p. 344
|
artikel
|
| 13 |
ASTCT Notes
|
|
|
|
|
6 |
p. 521
|
artikel
|
| 14 |
A Timely CIBMTR Analysis of How Cryopreservation Impacts Allogeneic Hematopoietic Cell Transplantation to Apply in the COVID Era
|
Allan, David S.
|
|
|
|
6 |
p. 446-447
|
artikel
|
| 15 |
Bien plus Encore: Haplos Indeed Can be Completed on an Outpatient Basis
|
Murrieta-Álvarez, Iván
|
|
|
|
6 |
p. 519-520
|
artikel
|
| 16 |
Bridging the Gap: Early Transition and Hybrid Models of Care to Improve Access to Chimeric Antigen Receptor T Cell Therapy
|
Ahmed, Nausheen
|
|
|
|
6 |
p. 399-402
|
artikel
|
| 17 |
CD52/GPI− T-Cells Are Enriched for Alloreactive Specificity and Predict Acute Graft-Versus-Host-Disease After Stem Cell Transplantation
|
Kinsella, Francesca A.
|
|
|
|
6 |
p. 475.e1-475.e9
|
artikel
|
| 18 |
Change in Neurocognitive Performance Among Patients with Non-Hodgkin Lymphoma in the First Year after Chimeric Antigen Receptor T Cell Therapy
|
Hoogland, Aasha I.
|
|
|
|
6 |
p. 305.e1-305.e9
|
artikel
|
| 19 |
Clinical Presentation, Risk Factors, and Outcomes of Immune Effector Cell-Associated Neurotoxicity Syndrome Following Chimeric Antigen Receptor T Cell Therapy: A Systematic Review
|
Grant, Shakira J.
|
|
|
|
6 |
p. 294-302
|
artikel
|
| 20 |
CMV Triplex Vaccine to Enhance Adaptive NK and T-cell Reconstitution After Autologous Hematopoietic Cell Transplantation
|
Rashidi, Armin
|
|
|
|
6 |
p. 343.e1-343.e4
|
artikel
|
| 21 |
Colonization with Gastrointestinal Pathogens Prior to Hematopoietic Cell Transplantation and Associated Clinical Implications
|
Kubiak, Jeffrey
|
|
|
|
6 |
p. 499.e1-499.e6
|
artikel
|
| 22 |
Comparison of Pretransplantation Prediction Models for Nonrelapse Mortality in Patients with Myelofibrosis Undergoing Allogeneic Stem Cell Transplantation
|
Acosta-Medina, Aldo A.
|
|
|
|
6 |
p. 360.e1-360.e8
|
artikel
|
| 23 |
Cost Effectiveness Analysis of Tisagenlecleucel for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma in Japan
|
Wakase, Shiho
|
|
|
|
6 |
p. 506.e1-506.e10
|
artikel
|
| 24 |
COVID-19 Cliff Notes: A COVID-19 Multidisciplinary Care Compendium
|
Williams, Kirsten M.
|
|
|
|
6 |
p. 474.e1-474.e3
|
artikel
|
| 25 |
Cytomegalovirus Prophylaxis versus Pre-emptive Strategy: Different CD4+ and CD8+ T Cell Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation
|
Sperotto, Alessandra
|
|
|
|
6 |
p. 518.e1-518.e4
|
artikel
|
| 26 |
Demographics, Motivations, and Experiences of Participants in Transplantation or Cellular Therapy Fellowships
|
Banerjee, Rahul
|
|
|
|
6 |
p. 394.e1-394.e7
|
artikel
|
| 27 |
Early T-Cell Precursor Acute Lymphoblastic Leukemia and T/Myeloid Mixed Phenotype Acute Leukemia Possess Overlapping Characteristics and Both Benefit From CAG-Like Regimens and Allogeneic Hematopoietic Stem Cell Transplantation
|
Liu, Sining
|
|
|
|
6 |
p. 481.e1-481.e7
|
artikel
|
| 28 |
Early Time-to-Tocilizumab after B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy in Myeloma
|
Banerjee, Rahul
|
|
|
|
6 |
p. 477.e1-477.e7
|
artikel
|
| 29 |
Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States
|
McGuirk, Joseph
|
|
|
|
6 |
p. 505.e1-505.e9
|
artikel
|
| 30 |
Editorial Board
|
|
|
|
|
6 |
p. A8
|
artikel
|
| 31 |
Editorial Board
|
|
|
|
|
6 |
p. A9
|
artikel
|
| 32 |
Editorial Board
|
|
|
|
|
6 |
p. A7
|
artikel
|
| 33 |
Effect of Autograft CD34+ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors
|
Knight, Tristan E.
|
|
|
|
6 |
p. 380.e1-380.e9
|
artikel
|
| 34 |
Effect of Graft-versus-Host Disease on Post-Transplantation Outcomes following Single Cord Blood Transplantation Compared with Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Adult Acute Myeloid Leukemia
|
Konuma, Takaaki
|
|
|
|
6 |
p. 365.e1-365.e11
|
artikel
|
| 35 |
Effect of mTOR Inhibition with Sirolimus on Natural Killer Cell Reconstitution in Allogeneic Stem Cell Transplantation
|
Haroun-Izquierdo, Alvaro
|
|
|
|
6 |
p. 376.e1-376.e11
|
artikel
|
| 36 |
Efficacy of Allogeneic Hematopoietic Cell Transplantation for Autoimmune Diseases
|
Shifa, Iman
|
|
|
|
6 |
p. 489.e1-489.e9
|
artikel
|
| 37 |
Epidemiology and Treatment of Chronic Graft-versus-Host Disease Post-Allogeneic Hematopoietic Cell Transplantation: A US Claims Analysis
|
Bachier, Carlos R.
|
|
|
|
6 |
p. 504.e1-504.e6
|
artikel
|
| 38 |
Epitope Mismatch at HLA-DRB1 Associates with Reduced Relapse Risk in Cord Blood Transplantation for Standard-Risk Hematologic Malignancy
|
Morita-Fujita, Mari
|
|
|
|
6 |
p. 347.e1-347.e11
|
artikel
|
| 39 |
Extracorporeal Photopheresis as Graft-versus-Host Disease Prophylaxis: A Randomized Controlled Trial
|
Ali, Maryan M.
|
|
|
|
6 |
p. 364.e1-364.e11
|
artikel
|
| 40 |
Favorable Outcomes after Single Cord Blood Transplantation for Patients with High-Risk Hematologic Diseases: A Single-Institute Retrospective Analysis
|
Wada, Fumiya
|
|
|
|
6 |
p. 495.e1-495.e9
|
artikel
|
| 41 |
Feasibility and Efficacy of CD45RA+ Depleted Donor Lymphocytes Infusion After Haploidentical Transplantation With Post-Transplantation Cyclophosphamide in Patients With Hematological Malignancies
|
Castagna, Luca
|
|
|
|
6 |
p. 478.e1-478.e5
|
artikel
|
| 42 |
Feasibility of a New Model of Care for Allogeneic Stem Cell Transplantation Recipients Facilitated by eHealth: The MY-Medula Pilot Study
|
Redondo, Sara
|
|
|
|
6 |
p. 385.e1-385.e8
|
artikel
|
| 43 |
Frailty in Patients with Chronic Graft-versus-Host Disease
|
Rashid, Nahid
|
|
|
|
6 |
p. 367-374
|
artikel
|
| 44 |
Gut Microbiota Dysbiosis Associated with Persistent Fatigue in Hematopoietic Cell Transplantation Survivors
|
Farhadfar, Nosha
|
|
|
|
6 |
p. 498.e1-498.e8
|
artikel
|
| 45 |
Hematopoietic Cell Transplantation for Congenital Dyserythropoietic Anemia: A Report from the Pediatric Transplant and Cellular Therapy Consortium
|
Rangarajan, Hemalatha G.
|
|
|
|
6 |
p. 329.e1-329.e9
|
artikel
|
| 46 |
High Mortality of COVID-19 Early after Allogeneic Stem Cell Transplantation: A Retrospective Multicenter Analysis on Behalf of the German Cooperative Transplant Study Group
|
Schaffrath, Judith
|
|
|
|
6 |
p. 337.e1-337.e10
|
artikel
|
| 47 |
How Old is Too Old for CAR-T Cell Therapies in Multiple Myeloma?
|
Rajeeve, Sridevi
|
|
|
|
6 |
p. 343-344
|
artikel
|
| 48 |
Immunologic Monitoring after Allogeneic Stem Cell Transplantation: T-SPOT.CMV and QuantiFERON-CMV, Are They the Same?
|
Callens, Rutger
|
|
|
|
6 |
p. 392.e1-392.e7
|
artikel
|
| 49 |
Impact of Cryopreservation on Extracorporeal Photopheresis (ECP)-Treated Leukocyte Subsets
|
Trunk, Andrew D.
|
|
|
|
6 |
p. 396.e1-396.e5
|
artikel
|
| 50 |
Impact of Donor Age in Haploidentical-Post-Transplantation Cyclophosphamide versus Matched Unrelated Donor Post-Transplantation Cyclophosphamide Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia
|
Mehta, Rohtesh S.
|
|
|
|
6 |
p. 377.e1-377.e7
|
artikel
|
| 51 |
Impact of Donor-to-Recipient ABO Mismatch on Outcomes of Antithymocyte Globulin-Based Peripheral Blood Stem Cell-Derived Myeloablative Conditioning Haploidentical Stem Cell Transplantation
|
Wu, Yibo
|
|
|
|
6 |
p. 331.e1-331.e10
|
artikel
|
| 52 |
Impact of Induction With VCD Versus VRD on the Outcome of Patients With Multiple Myeloma After an Autologous Hematopoietic Stem Cell Transplantation
|
Afrough, Aimaz
|
|
|
|
6 |
p. 307.e1-307.e8
|
artikel
|
| 53 |
Impact of Next-Generation Sequencing Cell-free Pathogen DNA Test on Antimicrobial Management in Adults with Hematological Malignancies and Transplant Recipients with Suspected Infections
|
Yu, James
|
|
|
|
6 |
p. 500.e1-500.e6
|
artikel
|
| 54 |
Improved NK Cell Recovery Following Use of PTCy or Treg Expanded Donors in Experimental MHC-Matched Allogeneic HSCT
|
Wolf, Dietlinde
|
|
|
|
6 |
p. 303.e1-303.e7
|
artikel
|
| 55 |
Incidence of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease and Treatment with Defibrotide in Allogeneic Transplantation: A Multicenter Australasian Registry Study
|
Coutsouvelis, John
|
|
|
|
6 |
p. 383.e1-383.e10
|
artikel
|
| 56 |
Late relapse after hematopoietic stem cell transplantation for acute leukemia: a retrospective study by SFGM-TC
|
Kaphan, Eléonore
|
|
|
|
6 |
p. 362.e1-362.e12
|
artikel
|
| 57 |
Long-Term Incidence of Varicella Zoster Virus Disease in Adults Receiving Single-Unit Cord Blood Transplantation
|
Fukushi, Kahori
|
|
|
|
6 |
p. 339.e1-339.e7
|
artikel
|
| 58 |
Long-term Survival after Hematopoietic Cell Transplant for Sickle Cell Disease Compared to the United States Population
|
St. Martin, Andrew
|
|
|
|
6 |
p. 325.e1-325.e7
|
artikel
|
| 59 |
Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation
|
Phelan, Rachel
|
|
|
|
6 |
p. 335.e1-335.e17
|
artikel
|
| 60 |
Masthead (Purpose and Scope)
|
|
|
|
|
6 |
p. A6
|
artikel
|
| 61 |
Masthead (Purpose and Scope)
|
|
|
|
|
6 |
p. A6
|
artikel
|
| 62 |
Masthead (Purpose and Scope)
|
|
|
|
|
6 |
p. A6
|
artikel
|
| 63 |
Mechanisms of Thymic Repair of In Vitro-Induced Precursor T Cells as a Haploidentical Hematopoietic Stem Cell Transplantation Regimen
|
Lei, Yang-yang
|
|
|
|
6 |
p. 382.e1-382.e11
|
artikel
|
| 64 |
Multiple Breath Washout Testing to Identify Pulmonary Chronic Graft Versus Host Disease in Children After Hematopoietic Stem Cell Transplantation
|
Rayment, Jonathan H.
|
|
|
|
6 |
p. 328.e1-328.e7
|
artikel
|
| 65 |
Myeloablative Busulfan/Melphalan Consolidation following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma: Children's Oncology Group Trial ANBL12P1
|
Granger, M. Meaghan
|
|
|
|
6 |
p. 490.e1-490.e8
|
artikel
|
| 66 |
Myeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes—Long-Term Follow-Up of the BMT CTN 0901 Clinical Trial
|
Scott, Bart L.
|
|
|
|
6 |
p. 483.e1-483.e6
|
artikel
|
| 67 |
Myeloablative Versus Reduced-Intensity Conditioning With Fludarabine/Busulfan for Myelodysplastic Syndrome: A Propensity Score-Matched Analysis
|
Kurosawa, Shuhei
|
|
|
|
6 |
p. 323.e1-323.e9
|
artikel
|
| 68 |
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report
|
Williams, Kirsten M.
|
|
|
|
6 |
p. 452-466
|
artikel
|
| 69 |
Noninfectious Pulmonary Toxicity after Allogeneic Hematopoietic Cell Transplantation
|
Patel, Sagar S.
|
|
|
|
6 |
p. 310-320
|
artikel
|
| 70 |
Nonmyeloablative Conditioning Regimen Including Low-Dose Total Marrow/Lymphoid Irradiation Before Haploidentical Transplantation with Post-Transplantation Cyclophosphamide in Patients with Advanced Lymphoproliferative Diseases
|
Sarina, Barbara
|
|
|
|
6 |
p. 492.e1-492.e6
|
artikel
|
| 71 |
Nutritional Supplements and Complementary/Alternative Medications in Patients With Hematologic Diseases and Hematopoietic Stem Cell Transplantation
|
Mohty, Razan
|
|
|
|
6 |
p. 467-473
|
artikel
|
| 72 |
Officers and Directors of ASTCT
|
|
|
|
|
6 |
p. A9
|
artikel
|
| 73 |
Officers and Directors of ASTCT
|
|
|
|
|
6 |
p. A10
|
artikel
|
| 74 |
Officers and Directors of ASTCT
|
|
|
|
|
6 |
p. A8
|
artikel
|
| 75 |
Once-Daily Foscarnet Is Effective for Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation
|
Vittayawacharin, Pongthep
|
|
|
|
6 |
p. 397.e1-397.e6
|
artikel
|
| 76 |
Optimal Active Anti-Thymocyte Globulin Exposure Associated with Minimum Risk of Virus Reactivation and Comparable Acute Graft-Versus-Host Disease Under Adult Myeloablative Haploidentical Peripheral Blood Stem Cell Transplantation
|
Wang, HaiTao
|
|
|
|
6 |
p. 332.e1-332.e10
|
artikel
|
| 77 |
Outcomes for Patients With IDH-Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
|
Chen, Evan C.
|
|
|
|
6 |
p. 479.e1-479.e7
|
artikel
|
| 78 |
Outcomes of CD19-Directed Chimeric Antigen Receptor T Cell Therapy for Transformed Nonfollicular Lymphoma
|
Dong, Ning
|
|
|
|
6 |
p. 349.e1-349.e8
|
artikel
|
| 79 |
Ovarian Function and Spontaneous Pregnancy After Hematopoietic Stem Cell Transplantation for Leukemia Before Puberty: An L.E.A. Cohort Study
|
Chabut, Mathilde
|
|
|
|
6 |
p. 378.e1-378.e9
|
artikel
|
| 80 |
Pathogen-Specific Humoral Immunity and Infections in B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy Recipients with Multiple Myeloma
|
Josyula, Srirama
|
|
|
|
6 |
p. 304.e1-304.e9
|
artikel
|
| 81 |
Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma
|
Chakraborty, Rajshekhar
|
|
|
|
6 |
p. 388.e1-388.e6
|
artikel
|
| 82 |
Patterns and Predictors of Functional Decline after Allogeneic Hematopoietic Cell Transplantation in Older Adults
|
Huang, Li-Wen
|
|
|
|
6 |
p. 309.e1-309.e9
|
artikel
|
| 83 |
Phase I Dose-Finding, Safety, and Tolerability Trial of Romiplostim to Improve Platelet Recovery After UCB Transplantation
|
Christakopoulos, Georgios E.
|
|
|
|
6 |
p. 497.e1-497.e6
|
artikel
|
| 84 |
Physical Activity and Sleep Measures Using a Fitness Tracking Device during Hematopoietic Cell Transplantation: A Pilot Study
|
Jurdi, Najla El
|
|
|
|
6 |
p. 502.e1-502.e6
|
artikel
|
| 85 |
Post-Allogeneic HSCT Non-Infectious Pulmonary Toxicities: A CIBMTR Registry Retrospective Study
|
Huo, Jeffrey S.
|
|
|
|
6 |
p. 281
|
artikel
|
| 86 |
Pretransplant systemic metabolic profiles in allogeneic hematopoietic stem cell transplant recipients - identification of patient subsets with increased transplant-related mortality
|
Reikvam, Håkon
|
|
|
|
6 |
p. 375.e1-375.e14
|
artikel
|
| 87 |
Prevalence of and Factors Associated with Marital Distress among Hematopoietic Cell Transplantation Survivors: Results from a Large Cross-Sectional Study
|
Langer, Shelby L.
|
|
|
|
6 |
p. 333.e1-333.e7
|
artikel
|
| 88 |
Quality of Life, Physical Functioning, and Psychological Distress of Older Adults Undergoing Hematopoietic Stem Cell Transplantation
|
Newcomb, Richard
|
|
|
|
6 |
p. 387.e1-387.e7
|
artikel
|
| 89 |
Racial and Ethnic Differences in Attitudes, Perceptions, and Knowledge about Unrelated Hematopoietic Stem Cell Donation: A Study of Younger Newly Recruited Potential Donors
|
Hamed, Ahmed B.
|
|
|
|
6 |
p. 340.e1-340.e16
|
artikel
|
| 90 |
Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|
Auletta, Jeffery J.
|
|
|
|
6 |
p. 346.e1-346.e10
|
artikel
|
| 91 |
Risk Factors for Mortality in Hematopoietic Stem Cell Transplantation Recipients with Bloodstream Infection: Points To Be Addressed by Future Guidelines
|
Puerta-Alcalde, Pedro
|
|
|
|
6 |
p. 501.e1-501.e6
|
artikel
|
| 92 |
Safety and Efficacy of BCMA CAR-T Cell Therapy in Older Patients With Multiple Myeloma
|
Reyes, Kevin R.
|
|
|
|
6 |
p. 350-355
|
artikel
|
| 93 |
Selection of Conditioning Intensity for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia and Myelodysplasia - New Evidence Emerges
|
Freeman, Sylvie D
|
|
|
|
6 |
p. 443-445
|
artikel
|
| 94 |
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Immunogenicity among Chimeric Antigen Receptor T Cell Therapy Recipients
|
Aleissa, Muneerah M.
|
|
|
|
6 |
p. 398.e1-398.e5
|
artikel
|
| 95 |
Shorter Interdonation Interval Contributes to Lower Cell Counts in Subsequent Stem Cell Donations
|
Panch, Sandhya R.
|
|
|
|
6 |
p. 503.e1-503.e8
|
artikel
|
| 96 |
Sustained Hematopoietic Engraftment Potential after Prolonged Storage of Cryopreserved Hematopoietic Stem Cells Used in Salvage Autologous Stem Cell Transplantation
|
Makhani, Sarah S.
|
|
|
|
6 |
p. 306.e1-306.e7
|
artikel
|
| 97 |
Table of Contents
|
|
|
|
|
6 |
p. A10-A14
|
artikel
|
| 98 |
Table of Contents
|
|
|
|
|
6 |
p. A11-A16
|
artikel
|
| 99 |
Table of Contents
|
|
|
|
|
6 |
p. A9-A13
|
artikel
|
| 100 |
The Clinical Significance of BCR-ABL1 Mutations in Patients With Philadelphia Chromosome–Positive Chronic Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation
|
Tachibana, Takayoshi
|
|
|
|
6 |
p. 321.e1-321.e8
|
artikel
|
| 101 |
The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 Pandemic
|
Hsu, Jack W.
|
|
|
|
6 |
p. 507-516
|
artikel
|
| 102 |
The Frailty Factor: Quantifying a Familiar Foe in Chronic GVHD
|
DeFilipp, Zachariah
|
|
|
|
6 |
p. 345
|
artikel
|
| 103 |
The Future of Chronic Graft-Versus-Host Disease: Introduction to the 2020 National Institutes of Health Consensus Development Project Reports
|
Pavletic, Steven Z.
|
|
|
|
6 |
p. 448-451
|
artikel
|
| 104 |
The Impact of a Hematopoietic Cellular Therapy Pharmacist on Clinical and Humanistic Outcomes: A RE-AIM Framework Analysis
|
Andrick, Benjamin
|
|
|
|
6 |
p. 334.e1-334.e9
|
artikel
|
| 105 |
TP53 Mutations Are Associated with Increased Infections and Reduced Hematopoietic Cell Transplantation Rates in Myelodysplastic Syndrome and Acute Myeloid Leukemia
|
Marvin-Peek, Jennifer
|
|
|
|
6 |
p. 390.e1-390.e10
|
artikel
|
| 106 |
Use of Prescription Sialagogues for Management of Xerostomia in Chronic Graft-versus-Host-Disease
|
Mousavian, Mohammad
|
|
|
|
6 |
p. 480.e1-480.e5
|
artikel
|
Tijdschrift beschrijving